Abiopharma

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025

Invivyd to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Bio-Techne to Present at Upcoming Investor Conferences

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences

Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

Axsome Therapeutics to Participate in Upcoming Investor Conferences

BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Lillys Verzenio® (abemaciclib) increases overall survival in HR+, HER2-, high-risk early breast cancer with two years of therapy

Compass Pathways - Compass Pathways to Participate in Four Investor Conferences in September

Stout Stephen 🟢 acquired 25.6K shares (1 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 Transaction Date: Aug 25, 2025 | Filing ID: 189086